These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 28887991)
21. Effect of PEGylated superparamagnetic iron oxide nanoparticles (SPIONs) under magnetic field on amyloid beta fibrillation process. Mirsadeghi S; Shanehsazzadeh S; Atyabi F; Dinarvand R Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():390-397. PubMed ID: 26652388 [TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor-alpha antibody labeled-polyethylene glycol-coated nanoparticles: A mesenchymal stem cells-based drug delivery system in the rat model of cisplatin-induced nephrotoxicity. Abo-Aziza FAM; Albarrak SM; Zaki AA; El-Shafey SE Vet World; 2022 Oct; 15(10):2475-2490. PubMed ID: 36425134 [TBL] [Abstract][Full Text] [Related]
23. Superparamagnetic Iron-Oxide Nanoparticles Synthesized via Green Chemistry for the Potential Treatment of Breast Cancer. Tyagi N; Gupta P; Khan Z; Neupane YR; Mangla B; Mehra N; Ralli T; Alhalmi A; Ali A; Al Kamaly O; Saleh A; Nasr FA; Kohli K Molecules; 2023 Mar; 28(5):. PubMed ID: 36903587 [TBL] [Abstract][Full Text] [Related]
24. Synthesis, characterization and theranostic evaluation of Indium-111 labeled multifunctional superparamagnetic iron oxide nanoparticles. Zolata H; Abbasi Davani F; Afarideh H Nucl Med Biol; 2015 Feb; 42(2):164-70. PubMed ID: 25311750 [TBL] [Abstract][Full Text] [Related]
25. Attachment of streptavidin-modified superparamagnetic iron oxide nanoparticles to the PC-12 cell membrane. Han D; Zhang B; Su L; Yang B Biomed Mater; 2020 Jun; 15(4):045014. PubMed ID: 32069444 [TBL] [Abstract][Full Text] [Related]
26. Synthesis, characterization and in vitro evaluation of exquisite targeting SPIONs-PEG-HER in HER2+ human breast cancer cells. Almaki JH; Nasiri R; Idris A; Majid FA; Salouti M; Wong TS; Dabagh S; Marvibaigi M; Amini N Nanotechnology; 2016 Mar; 27(10):105601. PubMed ID: 26861770 [TBL] [Abstract][Full Text] [Related]
27. In Vivo Distribution of Poly(ethylene glycol) Functionalized Iron Oxide Nanoclusters: An Ultrastructural Study. Suciu M; Mirescu C; Crăciunescu I; Macavei SG; Leoștean C; Ştefan R; Olar LE; Tripon SC; Ciorîță A; Barbu-Tudoran L Nanomaterials (Basel); 2021 Aug; 11(9):. PubMed ID: 34578500 [TBL] [Abstract][Full Text] [Related]
28. Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer. Luo X; Peng X; Hou J; Wu S; Shen J; Wang L Int J Nanomedicine; 2017; 12():5331-5343. PubMed ID: 28794626 [TBL] [Abstract][Full Text] [Related]
29. Feasibility of implantable iron oxide nanoparticles in detecting brain activity-proof of concept in a rat model. Champagne PO; Sanon NT; Carmant L; Pouliot P; Bouthillier A; Sawan M Epilepsy Res; 2021 May; 172():106585. PubMed ID: 33636503 [TBL] [Abstract][Full Text] [Related]
30. Accumulation and Toxicity of Superparamagnetic Iron Oxide Nanoparticles in Cells and Experimental Animals. Jarockyte G; Daugelaite E; Stasys M; Statkute U; Poderys V; Tseng TC; Hsu SH; Karabanovas V; Rotomskis R Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548152 [TBL] [Abstract][Full Text] [Related]
32. Folic acid-capped PEGylated magnetic nanoparticles enter cancer cells mostly via clathrin-dependent endocytosis. Allard-Vannier E; Hervé-Aubert K; Kaaki K; Blondy T; Shebanova A; Shaitan KV; Ignatova AA; Saboungi ML; Feofanov AV; Chourpa I Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1578-1586. PubMed ID: 27919801 [TBL] [Abstract][Full Text] [Related]
33. Triple Therapy of HER2 Zolata H; Afarideh H; Davani FA Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759 [TBL] [Abstract][Full Text] [Related]
34. PEGylated Bilirubin-coated Iron Oxide Nanoparticles as a Biosensor for Magnetic Relaxation Switching-based ROS Detection in Whole Blood. Lee DY; Kang S; Lee Y; Kim JY; Yoo D; Jung W; Lee S; Jeong YY; Lee K; Jon S Theranostics; 2020; 10(5):1997-2007. PubMed ID: 32104497 [No Abstract] [Full Text] [Related]
35. Biomimetic Modification and In Vivo Safety Assessment of Superparamagnetic Iron Oxide Nanoparticles. Song X; Gu X; Sun H; Fu C; Zhang Y; Dong P J Nanosci Nanotechnol; 2016 Apr; 16(4):4100-7. PubMed ID: 27451771 [TBL] [Abstract][Full Text] [Related]
36. Enhanced Homing Technique of Mesenchymal Stem Cells Using Iron Oxide Nanoparticles by Magnetic Attraction in Olfactory-Injured Mouse Models. Yun WS; Choi JS; Ju HM; Kim MH; Choi SJ; Oh ES; Seo YJ; Key J Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29734748 [TBL] [Abstract][Full Text] [Related]
37. Pegylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness in vitro and in vivo. Allard-Vannier E; Cohen-Jonathan S; Gautier J; Hervé-Aubert K; Munnier E; Soucé M; Legras P; Passirani C; Chourpa I Eur J Pharm Biopharm; 2012 Aug; 81(3):498-505. PubMed ID: 22510695 [TBL] [Abstract][Full Text] [Related]
38. Cellular interactions of functionalized superparamagnetic iron oxide nanoparticles on oligodendrocytes without detrimental side effects: Cell death induction, oxidative stress and inflammation. Sruthi S; Maurizi L; Nury T; Sallem F; Boudon J; Riedinger JM; Millot N; Bouyer F; Lizard G Colloids Surf B Biointerfaces; 2018 Oct; 170():454-462. PubMed ID: 29958160 [TBL] [Abstract][Full Text] [Related]